Keywords: aventis, takes, antihistamine, market, once-daily, allegra, been

Aventis takes on US antihistamine market with once-daily Allegra

Article | 29 February 2000

Print This

Aventis has been granted approval by the US Food and Drug Administrationfor a new once-daily 180mg formulation of Allegra (fexofenadine), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in